These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 2704422

  • 1. Circulating immune complexes in acute leukemia.
    Cermák J, Feyereislová A, Horejsí J.
    Neoplasma; 1989; 36(1):21-7. PubMed ID: 2704422
    [Abstract] [Full Text] [Related]

  • 2. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
    Larson RA, Lukin CL, Daly KM, Mick R, Gore S, Le Beau MM.
    Leukemia; 1991 Feb; 5(2):131-7. PubMed ID: 2020195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects.
    Paydas S, Tanriverdi K, Yavuz S, Disel U, Baslamisli F, Burgut R.
    Am J Hematol; 2005 Aug; 79(4):257-61. PubMed ID: 16044453
    [Abstract] [Full Text] [Related]

  • 6. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot G, Weber G.
    Anticancer Res; 1996 Aug; 16(6A):3341-7. PubMed ID: 9042309
    [Abstract] [Full Text] [Related]

  • 7. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM, Ashtekar MD, Ganatra RD.
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [Abstract] [Full Text] [Related]

  • 8. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Tomasević Z, Jelić S.
    Arch Immunol Ther Exp (Warsz); 2000 Nov; 48(3):195-200. PubMed ID: 10912625
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP, Finn WG, Singleton TP, Schnitzer B, Ross CW.
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
    Zhang GC, Zheng D, Li QH, Li XH, Cai CC, Luo SK, Li J, Peng AH, Tong XZ, Tan EX, Hong WD.
    Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
    [Abstract] [Full Text] [Related]

  • 12. Circulating immune complexes and the prognosis of acute myeloid leukemia.
    Carpentier NA, Fiere DM, Schuh D, Lange GT, Lambert PH.
    N Engl J Med; 1982 Nov 04; 307(19):1174-80. PubMed ID: 6956807
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up.
    Lahaye T, Riehm B, Berger U, Paschka P, Müller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A.
    Cancer; 2005 Apr 15; 103(8):1659-69. PubMed ID: 15747376
    [Abstract] [Full Text] [Related]

  • 15. [Study on correlation and clinical significance of superoxide dismutase (SOD) activity and content in 102 patients with leukemia].
    Zhu CS, Zhang CY, Weng WQ.
    Zhonghua Zhong Liu Za Zhi; 1994 Jan 15; 16(1):39-42. PubMed ID: 8033747
    [Abstract] [Full Text] [Related]

  • 16. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z, Takahashi M, Aoki S, Toba K, Liu A, Osman Y, Takahashi H, Tsukada N, Suzuki N, Nikkuni K, Furukawa T, Koike T, Aizawa Y.
    J Exp Clin Cancer Res; 1998 Sep 15; 17(3):251-8. PubMed ID: 9894758
    [Abstract] [Full Text] [Related]

  • 17. Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).
    Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.
    Ann Hematol; 2006 Jun 15; 85(6):366-73. PubMed ID: 16523310
    [Abstract] [Full Text] [Related]

  • 18. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Jun 15; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 19. Platelet function in acute leukemias.
    Naresh KN, Sivasankaran P, Veliath AJ.
    J Assoc Physicians India; 1993 Jun 15; 41(6):377-8. PubMed ID: 8005978
    [Abstract] [Full Text] [Related]

  • 20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI.
    Genes Chromosomes Cancer; 2003 Jul 15; 37(3):291-9. PubMed ID: 12759927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.